Chinook Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Chinook Therapeutics

15/05/2021 09:31

* Chinook Therapeutics Inc  KDNY.OQ  reported a quarterly
adjusted loss of 88 cents​​ per share for the quarter ended
in March. The mean expectation of five analysts for the quarter
was for a loss of 68 cents per share.
* Revenue fell 97.5% to $351.00 thousand from a year ago; 
analysts expected $50.00 thousand. 
* Chinook Therapeutics Inc's reported EPS for the quarter was a
loss of 88 cents​.
* The mean earnings estimate of analysts had fallen by
about 52.6% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Chinook Therapeutics Inc shares had fallen by 3.5% this
quarter and lost 5.5% so far this year.
* The company reported a quarterly loss of $37.22 million.
* Wall Street's median 12-month price target for Chinook
Therapeutics Inc is $31.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 8 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 15 at 08:31 a.m. GMT.
​All figures in US dollars